Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Clarke

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Vaccine|April 11, 2017
Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13Johannes Trück, Amber Thompson, Begonia Morales-Aza, et al.
BMC Infectious Diseases|July 13, 2023
Prevalence of five treatable sexually transmitted infections among women in Lower River region of The GambiaRobert Butcher, Sheikh Jarju, Dolapo Obayemi, et al.
Msphere|November 9, 2018
The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization ProgramsFlor M Munoz, Pierre Van Damme, Ener Dinleyici, et al.
Vaccine|January 11, 2025
Immunogenicity of yellow fever vaccine co-administered with 13-valent pneumococcal conjugate vaccine in rural Gambia: A cluster-randomised trialIsaac Osei, Jonas Schmidt-Chanasit, Paul V Licciardi, et al.
Therapeutic Innovation & Regulatory Science|January 29, 2024
Practical Guidelines for Standardised Resolution of Important Protocol Deviations in Clinical Trials Conducted in Sub-Saharan AfricaArmel Zemsi, Lorraine Jinette Guedem Nekame, Nuredin Mohammed, et al.
Reproductive Health|May 5, 2026
The design and use of ACASI to elicit sexual behaviour in the PHASE survey - the Gambian experienceAdedapo O Bashorun, Larry Kotei, Ousubie Jawla, et al.
Vaccine|December 18, 2019
Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trialEd Clarke, Adedapo O Bashorun, Michael Okoye, et al.
Frontiers in Immunology|September 1, 2017
Negative Correlation between Circulating CD4<sup>+</sup>FOXP3<sup>+</sup>CD127<sup>-</sup> Regulatory T Cells and Subsequent Antibody Responses to Infant Measles Vaccine but Not Diphtheria-Tetanus-Pertussis Vaccine Implies a Regulatory RoleJorjoh Ndure, Fatou Noho-Konteh, Jane U Adetifa, et al.
Msphere|January 28, 2021
The Fifth International Neonatal and Maternal Immunization Symposium (INMIS 2019): Securing Protection for the Next GenerationManish Sadarangani, Tobias Kollmann, Gordean Bjornson, et al.
The Lancet. Infectious Diseases|January 13, 2023
Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trialIkechukwu Adigweme, Ahmed Futa, Ebrima Saidy-Jah, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Vaccine|April 11, 2017
Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13Johannes Trück, Amber Thompson, Begonia Morales-Aza, et al.
BMC Infectious Diseases|July 13, 2023
Prevalence of five treatable sexually transmitted infections among women in Lower River region of The GambiaRobert Butcher, Sheikh Jarju, Dolapo Obayemi, et al.
Msphere|November 9, 2018
The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization ProgramsFlor M Munoz, Pierre Van Damme, Ener Dinleyici, et al.
Vaccine|January 11, 2025
Immunogenicity of yellow fever vaccine co-administered with 13-valent pneumococcal conjugate vaccine in rural Gambia: A cluster-randomised trialIsaac Osei, Jonas Schmidt-Chanasit, Paul V Licciardi, et al.
Therapeutic Innovation & Regulatory Science|January 29, 2024
Practical Guidelines for Standardised Resolution of Important Protocol Deviations in Clinical Trials Conducted in Sub-Saharan AfricaArmel Zemsi, Lorraine Jinette Guedem Nekame, Nuredin Mohammed, et al.
Reproductive Health|May 5, 2026
The design and use of ACASI to elicit sexual behaviour in the PHASE survey - the Gambian experienceAdedapo O Bashorun, Larry Kotei, Ousubie Jawla, et al.
Vaccine|December 18, 2019
Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trialEd Clarke, Adedapo O Bashorun, Michael Okoye, et al.
Frontiers in Immunology|September 1, 2017
Negative Correlation between Circulating CD4<sup>+</sup>FOXP3<sup>+</sup>CD127<sup>-</sup> Regulatory T Cells and Subsequent Antibody Responses to Infant Measles Vaccine but Not Diphtheria-Tetanus-Pertussis Vaccine Implies a Regulatory RoleJorjoh Ndure, Fatou Noho-Konteh, Jane U Adetifa, et al.
Msphere|January 28, 2021
The Fifth International Neonatal and Maternal Immunization Symposium (INMIS 2019): Securing Protection for the Next GenerationManish Sadarangani, Tobias Kollmann, Gordean Bjornson, et al.
The Lancet. Infectious Diseases|January 13, 2023
Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trialIkechukwu Adigweme, Ahmed Futa, Ebrima Saidy-Jah, et al.
Pageof 6